-The Telegraph New Delhi: The Indian government is mulling monetary incentives to private doctors who provide correct treatment to patients with tuberculosis and financial and nutritional support to patients under new strategies to eliminate TB as a public health problem by 2025. The Union health ministry's "national strategic plan for tuberculosis elimination 2017-2025" also seeks to enhance investments in diagnostic tools and treatment to help cut the country's new TB cases from...

-The Telegraph New Delhi: A health consortium today questioned a decision by Delhi High Court earlier this week to quash the Centre's ban on 344 cocktails of two or more medicines and urged doctors across the country to stop prescribing them. The Jan Swasthya Abhiyan (JSA), the Indian section of the global People's Health Movement, said it was shocked at the judgment because there was "no scientific rationale" for the continued use...

-The Hindu Medicines remain overpriced and unaffordable in India. In a country mired in poverty, medical debt remains the second biggest factor for keeping millions in poverty. The international pharmaceutical industry has found its cash cow in India’s beleaguered consumers. With a minimum wage of Rs.250/day for a government worker, a basic wage worker afflicted with a chronic disease like multi-drug-resistant tuberculosis faces penury. His treatment, with drug combinations, which works out...

-The Times of India MUMBAI/NEW DELHI: Medicines widely used to treat diabetes, infections, pain and digestive disorders will cost 5-40% less with immediate effect, with the drug price regulator issuing an order to fix the prices of 39-odd formulations. The National Pharmaceutical Pricing Authority's (NPPA) order, issued on Wednesday, includes drug combinations such as ciprofloxacin hydrochloride, cefotaxime, paracetamol, domperidone and metformin + glimepiride and amoxycillin + potassium clavulanate. These drugs and combinations are...

-The Telegraph New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment. Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse. A consortium of...